Keywords
Adolescents
Young adults
Type 1 diabetes
Categories
How to Cite
Abstract
Objectives This study aimed to evaluate the electrocardiographic (ECG) profile of young Cameroonian subjects living with T1D. Methodology A descriptive and analytical cross-sectional study was conducted from December 2016 to May 2017. The study population included 89 patients with type 1 diabetes (T1D), recruited from the diabetes care unit of the Yaoundé Central Hospital and 89 gender-matched control subjects, and recruited from schools in the city of Yaoundé. Each participant underwent a full clinical evaluation (history, weight, height, and blood pressure) and a resting electrocardiogram. The outcome variables analysed were the existence of arrhythmias, conduction defects, ventricular hypertrophy, atrial enlargement, ischemic changes, and repolarisation defects. Data were analysed using Epi Info version 7 software. Continuous data are presented as mean ± standard deviation. ANOVA and Chi-squared tests were used to compare means and proportions, respectively. Electrical abnormalities were compared by calculating the Odds Ratio (OR). A p-value of <0.05 was considered statistically significant. Results Their mean age was 18.3 ±4.2 years for the cases (T1D), and 14.7 ± 2.2 years for the controls (p<0.001). Sex, weight, and systolic blood pressure (BP) were similar in both groups. In the DT group, the mean duration of diabetes was 4.7±3.5 years, the mean HbA1c was 8.7 ± 2.1%, and the mean daily insulin was 46.5 ± 17 UI. The Cases had significantly higher mean diastolic BP than controls (72.7±8.5 versus 64.1±7.4, p<0.001). The cases had significantly lower mean heart rate (74±11.9beats/min versus 80±13.6, p=0.002), longer P wave duration (104±10ms versus 84±10, p<0.00), longer QRS duration (86±10ms versus 71±20, p<0.001), shorter PR interval (149±20ms versus 156± 156±20, p=0.004). No pre-excitation, nor conduction defect was seen in the cases. The mean peripheral voltage criteria for ventricular hypertrophy (Cornell and Lewis indices) were similar between groups. The mean precordial (Sokolow index) criteria was significantly lower in the cases (22.1±5.6mm versus 24.7±7.2, p=0.009). Sinus arrhythmia (OR: 2.3, p=0.01), early repolarisation pattern (OR 16.4, p=0.001), left atrial enlargement (OR: 9.9, p=0.018), and Q waves in two concordant leads (OR: 4.3, p<0.001) were significantly more frequent in the cases. Moritz sign (predominantly negative biphasic P wave in V1) was significantly more frequent in controls (p=0.03). One case of Wolf-Parkinson-White pattern, one case of wandering pacemaker, were seen in the controls. The ECG changes in the cases were not associated with the dose of insulin, duration of diabetes, or HbA1c. Conclusion After approximately five years of T1D evolution, the ECG profile in adolescents and young adults shows significant changes compared to non-diabetics. These alterations notably include frequent sinus arrhythmia, left atrial enlargement, concordant Q waves, an early repolarisation pattern, and lower precordial voltage criteria (Sokolow index). They also had a significantly longer QRS and QTc duration, and a lower heart rate.
References
[1] Magliano DJ, Zimmet P, Shaw JE. Classification of diabetes mellitus and other categories of glucose intolerance. International Textbook of Diabetes Mellitus: John Wiley & Sons, Ltd; 2015. p. 1-16.
[2] Fédération Internationale du Diabète. IDF Diabetes Atlas. Brussels, Belgium: International Diabetes Federation; 2015. Seventh edition
[3] Association AD. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010 33(Supplement 1):S62-S9.
[4] Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017; 128:40-50.
[5] Watkins PJ, Amiel SA, Howell SL, Turner E. Diagnosis and Classification. Diabetes and its Management: Blackwell Publishing Ltd; 2008. p. 1-15.
[6] Beran D, Yudkin JS. Diabetes care in sub-Saharan Africa. Lancet (London, England). 2006 ;368(9548):1689-95.
[7] Lokrou A, Katche A, V., Timite-Konan M. Le diabète de l’enfant de l’adolescent en Côte d’Ivoire. Rev Fr Endocrinol Clin Nutr Métabolisme. 1995;36(6):551-6.
[8] Sobngwi E, Mauvais-Jarvis F, Vexiau P, Mbanya JC, Gautier JF. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Metab. Dec 2001; 27(6):628-34.
[9] Sarr M, Fall M, Diouf S, Moreira C, Signate - Sy H, Ba M. Aspect général du diabète de l’enfant au service de pédiatrie du CHU de Dakar. Arch Pediatr 1990;37(7).
[10] Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007; 28(1):88-136.
[11] GRIMALDI A. Traité de diabétologie. 2ème édition : Flammarion Médecine-sciences; 2009.
[12] Louis M, Jean-François T. Diabète sucré : Complications du diabète. Revue du praticien. 2007;57(6):653-64.
[13] American Diabetes Association. Standards of Medical Care in Diabetes—2015. Clinical and applied research and education. 2015; 38:s1-s94.
[14] Mbanya JC, Sobngwi E. Diabetes in Africa. Diabetes microvascular and macrovascular disease in Africa. Journal of Cardiovascular Risk. Apr 2003; 10(2):97-102.
[15] Van Hecke MV, Dekker JM, Stehouwer CD. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care. 2005; 28(2):97-102.
[16] Tesfaye S, Boulton AJ, Dyck PJ. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(2):97-102.
[17] Perlemuter l, Sélam jl, Collin de l'hortet g. Diabète et maladies métaboliques.2003 ;(2):408.
[18] Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia.2001; 44 Suppl 2:S14-21.
[19] Soedamah-Muthu SS, Stehouwer CD. Cardiovascular disease morbidity and mortality in patients with type 1 diabetes mellitus: management strategies. Treatments in endocrinology. 2005; 4(2):75-86.
[20] Rossing P, Breum L, Major-Pedersen A, Sato A, Winding H, Pietersen A. Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabetic medicine: a journal of the British Diabetic Association. 2001; 18(3):199-205.
[21] Soliman EZ, Backlund JC, Bebu I, Orchard TJ, Zinman B, Lachin JM. Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care.. 2017; 40(6):793-9.
[22] Soliman EZ, Backlund JYC, Bebu I, Li Y, Zhang ZM, Cleary PA, et al. Progression of Electrocardiographic Abnormalities in Type 1 Diabetes during 16 Years of Follow‐up: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2016;46(5):570-5..
[23] O'Neal WT, Lee KE, Soliman EZ, Klein R, Klein BE. Predictors of electrocardiographic abnormalities in type 1 Diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Journal of Endocrinological Investigation. 2017; 40(3):313-8.
[24] Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J. Diabetes and infection: assessing the association with glycaemic control in population-based studies. The Lancet Diabetes & Endocrinology. 2003; 10(2):97-102.
[25] Dorchy H. Traitement du diabète de type 1 chez l’enfant et l’adolescent. Rev. Prat. 1996;46(5):577-86.
[26] Bougnères P. Pronostic et objectifs thérapeutiques du diabète de l’enfant: Diabètes de l’enfant. Revue du praticien.1996;46(5):570-5.
[27] Coluzzi G, Pelargonio G, Pitocco D, Sanna T, Casella M, Russo AD et al. Intraventricular conduction abnormalities in young patients with type 1 diabetes mellitus. J Cardiovasc Med (Hagerstown). 2008; 9:714-715.
[28] Longo D, Fauci A, Kasper D, Hauser S, Jameson J. Harrisons Manual of Medicine, 18th Edition: McGraw-Hill Education; 2012.
[29] Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited. Diabetologia. 2009; 52(1):42-5.
[30] Traon AP, Fontaine S, Tap G, Guidolin B, Senard JM, Hanaraire H. Cardiovascular autonomic neuropathy and other complications in type 1 diabetes. Clin Auton Res. 2010; 20:153-160.
[31] Soliman EZ, Backlund JC, Bedu, Orchard BZ, Lachin JM and the DCCT/EDIC Research Group. Electrocardiographic abnormalities and cardiovascular disease risk in type 1 diabetes interventions and complications (EDIC) study. Diabetes care. 2017;46(5):570-5..
[32] Jingi AM, Noubiap JJ, Kamdem P, Kingue S. Determinants and improvement of electrocardiographic diagnosis of left ventricular hypertrophy in a black African population. Plos One. 2014 May 8; 9(5): e96783
[33] Galli-Tsinopoulou A, Chatzidimitriou A, Kyrgios L, Rousso I, Varlamis G, Karavanaki K. Children and adolescents with type 1 diabetes mellitus have a sixfold greater risk for prolonged QTc interval. J Pediatric Met.2014; 27(3-4):237-243.
[34] Youssef O, I. Farid SM.. QTc and QTd in children with type 1 diabetes mellitus during diabetic ketoacidosis. International Scholarly research Network Pediatrics.. 2012; 46(5):570-5.
[35] Monabeka H, G., Mbika‐Cardorelle A, Moyen G. Acidocétose chez l’enfant et l’adolescent au Congo. Cahiers d'études et de recherches francophones / santé. 2003;13(3):139-41.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Frontiers in Preventive Medicine